Fundraising Fox
Cape Fear BioCapital
Venture capitalActively deployingDurham · Pre-Seed–Seed · 3 people tracked
Find your way into Cape Fear BioCapital
Sign up to see every warm intro you have to Cape Fear BioCapital
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Cape Fear BioCapital team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
Cape Fear BioCapital invests at the earliest stages in therapeutics companies rooted in North Carolina's life sciences ecosystem, drawing on innovation from Duke, UNC, NC State, and the broader NC corridor. The firm writes first checks and joins syndicates, aiming to create seed-ready opportunities from academic science. It targets companies with genuinely differentiated biology — validated mechanisms, novel modalities, and category-creating platforms — and backs both multi-indication platform companies and single-asset programs. It focuses on companies within roughly three years of an IND filing, where capital can accelerate the path to the clinic, and contributes hands-on operational experience and company-building support.
Source: firm website, verified Aug 11, 2026.
Team · 3 people
from the firm's website
What they invest in
from 5 of 6 portfolio companiesBiotech ×5Healthtech ×3AI & Machine Learning ×1Deep Tech ×1Hardware ×1Medical Devices ×1
HQs:United States×5
Investments · 6 tracked
founders shown can be your intro pathBy year:2026 · 12025 · 22021 · 14 dated
Eldec is a biotechnology company developing peptide-based therapeutics targeting SPLUNC1's modulation of Orai1 activity, with lead programs ELD615 and ELD607 for lung diseases such as cystic fibrosis and non-CF bronchiectasis.
BiotechHealthtechChapel Hill, US
Robert Tarran(Co-founder, President and Chief Scientific Officer)inSaira Ahmad(Co-founder; Director of Science)inFlori Sassano(Co-founder; Director, Research Operations)Robert J. Schotzinger(Chairman and Chief Executive Officer)Robert Hughes(Chief Financial Officer)Dale J. Christensen(Chief Development Officer)
Incyclix Bio develops precision cancer treatments targeting the CDK family of enzymes to restore cell cycle control in tumors, including CDK targets beyond CDK4/6 such as CDK2.
BiotechHealthtechDurham, US
Patrick Roberts(Executive Officer and member of the Board of Managers.)in
BoardFredric N. Eshelman(Executive Officer and member of the Board of Managers.)Sid Subramony(Member of the Board of Managers.)Norman Sharpless(Member of the Board of Managers.)
Co-investorsEshelman Ventures, LLCHatteras Venture PartnersHatteras
iOrganBio builds CellForge, an AI- and automation-driven platform for engineering and manufacturing human cells and organoids.
Co-investorsFirst Star VenturesHartmann CapitalSOSVAlix VenturesIndieBio
Ten63 develops drug-discovery technology that combines generative chemistry with quantum-accurate molecular simulation, including BEYOND (a large quantum chemistry model) and Sentinel (a virtual CSO for target selection), to design therapeutics against previously undruggable targets.
AI & Machine LearningBiotechDeep TechDurham, US
Mark A. Hallen(Executive Officer, Director)inMarcel Frenkel(Executive Officer, Director)Damien Petty(Director)inJia Wei Xu(Director)
Co-investorsDFJ DragonFundDraper AssociatesDuke Capital PartnersHatteras Venture PartnersSOSVAbbVie+4 more
Thoracic Innovations is a medical device company that develops products using computer-aided design, rapid prototyping, and 3D printing, with a focus on the cardiothoracic and thoracic clinical area.
BiotechHardwareHealthtechMedical DevicesChapel Hill, US
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Portfolio news
latest coverage across their companiesiOrganBio · finsmes.com · Oct 30, 2025
Eldec Pharmaceuticals · eldecpharmaceuticals.com · Apr 9, 2025
Frequently asked questions
- How many investments has Cape Fear BioCapital made?
- Cape Fear BioCapital has 6 tracked investments, including 3 dated in the last 24 months.
- What stage does Cape Fear BioCapital invest at?
- Cape Fear BioCapital invests at the Pre-Seed, Seed stages.
- What sectors does Cape Fear BioCapital focus on?
- Cape Fear BioCapital focuses on AI & Machine Learning, Biotech, Digital Health, Healthtech, Medical Devices.
- Where is Cape Fear BioCapital located?
- Cape Fear BioCapital is headquartered in Durham, US.
- Does Cape Fear BioCapital lead rounds?
- Yes, Cape Fear BioCapital leads investment rounds.
- Who does Cape Fear BioCapital co-invest with?
- Cape Fear BioCapital most often shares deals with Hatteras Venture Partners, SOSV, Draper Associates, among 8 tracked co-investors.
Similar investors
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests in technology companies from seed to growth stage. Since inception it has backed over 200 companies and raised more than $1.3 billion.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Breyer Capital is a venture capital firm that backs high-impact entrepreneurs, making strategic investments guided by founder passion and its network of experienced investors.
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
Future Positive Capital is a venture firm backing entrepreneurs building companies that address large-scale global challenges across health, sustainability and technology.